Henry Rosevear, MD

Physician employment: Both good and bad resultsDr. Henry Rosevear looks at how practices have changed since he entered into medicine and what these changes mean for urologists.
Do you own an S corp? Why I made the switchHenry Rosevear, MD, discusses the pros and cons of S corporations and why he decided to create one.
On-Demand and on-target: Why AUA Course Pass is worth your time
On-Demand and on-target: Why AUA Course Pass is worth your timeHenry Rosevear, MD, discusses his experience with the On-Demand Course Pass for this year’s AUA annual meeting, including the two On-Demand courses he found most informative.
Burnout, biopsy, BPH, and more: Post-AUA reviewUrologist Henry Rosevear, MD, reviews his personal highlights from AUA 2017, along with a few bumps in the road.
Prior authorization and decision trees: Roots of my frustrationUrologist Henry Rosevear, MD, thinks it may be time to bring patients into the prior authorization process.
AUA 2017: A small-town plumber’s 10 can’t-miss sessionsIn preparation for the AUA annual meeting in May, urologist Henry Rosevear, MD, shares the 10 sessions he’s looking forward to the most.
The ‘post-truth’ world: How it’s drifting into medicineHenry Rosevear, MD, examines how the political notion of a “post-truth” world has seeped into medicine.
Pain control: Let’s rethink our prescribing habitsDr. Henry Rosevear apologizes to those he may have hurt with his prescription habits for pain control and discusses the steps he is taking to help remedy the narcotics epidemic.
Looking ahead to 2017: A urologist’s wish listHenry Rosevear, MD, discusses the ten things he’d like to see happen in 2017 for the field of urology.
Apparently, I'm worth less than a staplerUrologist Henry Rosevear, MD, discusses a recent OR experience that had him rethink his value as a surgeon and consider a possible alternative to better align the financial incentives of the surgeon with the hospital's goals.